argenx SE | ARGX - Ebit

Stock Price
666.20
Daily Change
-19.20 -2.80%
Monthly
10.81%
Yearly
24.34%
Q2 Forecast
651.81

argenx SE reported $371.14M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
AstraZeneca USD 2.97B 4.48B Dec/2025
Galapagos EUR 780.56M 822.23M Dec/2025
Genmab DKK 260M 199M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
GRIFOLS EUR 352.11M 20.18M Sep/2025
Hikma Pharmaceutical USD 348M 31M Dec/2025
Qiagen NV USD 121.88M 19.18M Dec/2025
UCB EUR 1.29B 571M Dec/2025